Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 22;82(8):721-734.
doi: 10.1016/j.jacc.2023.05.061.

ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases: JACC Guideline Comparison

Augustin Coisne  1 , Patrizio Lancellotti  2 , Gilbert Habib  3 , Madalina Garbi  4 , Jordi Sanchez Dahl  5 , Marco Barbanti  6 , Mani A Vannan  7 , Vassilios S Vassiliou  8 , Dariusz Dudek  9 , Ovidiu Chioncel  10 , Johannes L Waltenberger  11 , Victoria L Johnson  12 , Ruggero De Paulis  13 , Rodolfo Citro  14 , Philippe Pibarot  15 ; EuroValve Consortium
Affiliations
Free article
Review

ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases: JACC Guideline Comparison

Augustin Coisne et al. J Am Coll Cardiol. .
Free article

Erratum in

  • Correction.
    [No authors listed] [No authors listed] J Am Coll Cardiol. 2023 Oct 17;82(16):1648. doi: 10.1016/j.jacc.2023.09.001. J Am Coll Cardiol. 2023. PMID: 37821175 No abstract available.

Abstract

Valvular heart disease (VHD) is common and poses important challenges from the standpoints of diagnosis and therapeutic management. Clinical practice guidelines have been developed to help health care professionals to overcome these challenges and provide optimal management to patients with VHD. The American College of Cardiology, in collaboration with the American Heart Association, and the European Society of Cardiology, in collaboration with the European Association for Cardio-Thoracic Surgery, recently updated their guidelines on the management of VHD. Although these 2 sets of guidelines are generally concordant, there are some substantial differences between these guidelines, which may have significant implications for clinical practice. This review prepared on behalf of the EuroValve Consortium describes the consistencies and discrepancies between the guidelines and highlights the gaps in these guidelines and the future research perspectives to fill these gaps.

Keywords: comparison; guidelines; valvular heart disease.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures Dr Garbi was The NICE Topic Adviser for the NICE Guidelines on heart valve disease presenting in adults: investigation and management. Dr Dahl has received speaker fees from Edwards. Dr Barbanti has served as a consultant for Edwards Lifesciences, Medtronic, and Boston Scientific. Dr Vannan has received research grants and a speaker honorarium (to Piedmont Heart Institute, not to self) from Abbott, Medtronic, and Edwards Lifesciences. Dr Vassiliou served as an advisor for the NICE Guidelines on valvular heart disease (NG208) referred to in this paper; and has received grants for investigator-initiated research by Medtronic and B Braun Ltd. Dr de Paulis has received royalties from Edwards for a mitral ring; and has received speaker fees from Edwards and Medtronic. Dr Pibarot has received institutional research grants from Edwards Lifesciences, Medtronic, Pi-Cardia, Cardiac Success, and Roche Diagnostics. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.